The case for buying the biotech bounce By: CNBC.com News February 21, 2017 at 08:09 AM EST Two popular biotech exchange-traded funds have been on a tear lately, and some strategists see more upside ahead. Read More >> Related Stocks: Nasdaq Biotechnology Ishares ETF S&P Biotech SPDR